JPRN-UMIN000011177
Completed
未知
The efficacy and safety of combination therapy of adoptive immunotherapy with chemotherapy for advanced pancreatic cancer - Combination therapy of immunotherapy with chemotherapy for pancreatic cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tokai University School of Medicine
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Interstitial pneumonia 2\. Active autoimmune disease 3\. Uncontroled infection 4\. Severe drug allergy 5\. Continued steroid therapy 6\. Pregnancy 7\. HIV or HTLV\-1 positive
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
COMET TrialJPRN-jRCTs031180210Yokote Koutaro60
Completed
Not Applicable
Effectiveness and safety of Combination therapy of Ranibizumab and LuseOgliflozin in type 2 diabetes with diabetic Macular Edema, a parallel group comparison with the standard Treatment controlled by Glimepiride, multicenter, randomized, open-label trial. (COMET Trial)JPRN-UMIN000033961Chiba University60
Active, not recruiting
Phase 1
Safety and efficacy of combination treatment with rituximab and leflunomide in patients with active rheumatoid arthritis - Rituximab and Leflunomide in RAEUCTR2005-004582-41-GBniversity of Leeds15
Completed
Phase 2
Efficacy and tolerability of combination therapy with aprepitant,palonosetron,and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy for gynecological cancer(Phase II Study)gynecological cancerJPRN-UMIN000003820Kansai Clinical Oncology Group -Gynecologic Cancer Group-100
Completed
Not Applicable
A study on the efficacy of combination therapy of insulin and ipragliflozin in patients with type 2 diabetesJPRN-UMIN000014798Imamura clinic15